Effects of Replacing Diet Beverages With Water on Weight Loss and Plasma Glucose Control in Type 2 Diabetes
1 other identifier
interventional
81
1 country
1
Brief Summary
The purpose of the present study is to evaluate the effect of replacing diet beverages with water on weight loss and biochemical indicators for insulin sensitivity and cardiometabolic risk factors of diabetic obese and overweight female adults when they are in a multidisciplinary weight loss plan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes
Started Apr 2015
Shorter than P25 for not_applicable type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 6, 2015
CompletedFirst Posted
Study publicly available on registry
April 9, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedOctober 25, 2019
October 1, 2019
6 months
April 6, 2015
October 24, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weight loss
24 weeks
Secondary Outcomes (6)
Fasting plasma glucose
24 weeks
Insulin resistance (HOMA)
24 weeks
Lipid profiles
24 weeks
Waist circumference
24 weeks
BMI
24 Weeks
- +1 more secondary outcomes
Study Arms (2)
Diet Beverages (DBs)
EXPERIMENTALDiet beverages after the main meal+ Diet
Water
EXPERIMENTALWater after the main meal+ Diet
Interventions
Subjects are asked to have 250 ml DBs at the end of their lunch as the main meal, while they are on a multidisciplinary diet plan for 24 weeks.
Subjects are asked to have 250 ml water at the end of their lunch as the main meal, while they are on a multidisciplinary diet plan for 24 weeks.
Eligibility Criteria
You may qualify if:
- Diabetic female patient with 6.5\<H1AC\<7.2.
- Monotherapy with Metformin.
- years of age.
- Body mass index (BMI) between 27-35 kg/ m².
- Consume DBs regularly during their habitual diet.
- Must be able to have moderate exercise.
- Must be interested to have weight loss.
You may not qualify if:
- Participating in a research project involving weight loss or physical activity in the previous six months.
- Pregnancy or lactation during the previous 6 months, or planned pregnancy in the next six months.
- Taking medication that could affect metabolism or change body weight.
- Report heart problems, chest pain, and cancer within the last five years.
- Unwilling to change intake of beverages during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Novindiet Cliniclead
- University of Nottinghamcollaborator
- Tehran University of Medical Sciencescollaborator
Study Sites (1)
NovinDiet Clinic
Tehran, 1913635136, Iran
Related Publications (1)
Lohner S, Kuellenberg de Gaudry D, Toews I, Ferenci T, Meerpohl JJ. Non-nutritive sweeteners for diabetes mellitus. Cochrane Database Syst Rev. 2020 May 25;5(5):CD012885. doi: 10.1002/14651858.CD012885.pub2.
PMID: 32449201DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hamid R Farshchi, MD, PhD
NovinDiet Clinic, School of Life Sciences, The University of Nottingham
- PRINCIPAL INVESTIGATOR
Ameneh Madjd, Dr
NovinDiet Clinic, School of Life Sciences, The University of Nottingham
- PRINCIPAL INVESTIGATOR
Ian A Macdonald, Prof.
School of Life Sciences, The University of Nottingham
- PRINCIPAL INVESTIGATOR
Moira A Taylor, PhD
School of Life Sciences, The University of Nottingham
- PRINCIPAL INVESTIGATOR
Reza Malekzadeh, Prof.
Digestive Disease Research Institute, Tehran University of Medical Sciences
- PRINCIPAL INVESTIGATOR
Alireza Delavari, MD
Digestive Disease Research Institute, Tehran University of Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 6, 2015
First Posted
April 9, 2015
Study Start
April 1, 2015
Primary Completion
October 1, 2015
Study Completion
January 1, 2016
Last Updated
October 25, 2019
Record last verified: 2019-10